Burning Rock Biotech

$35.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.49 (-1.38%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell BNR and other stocks, options, and ETFs commission-free!

About BNR

Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The company operates through following segment: central laboratory business, in-hospital business and pharma research and development services. Its products and clinical applications including companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction, and tumor susceptibility tests. Burning Rock Biotech was founded by Yu Sheng Han in 2014 and is headquartered in Guangzhou, China. The listed name for BNR is Burning Rock Biotech Limited American Depositary Shares.

CEO
Yu Sheng Han
Employees
705
Headquarters
Guangzhou, Guangdong
Founded
2014
Market Cap
3.57B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
438.79K
High Today
$37.20
Low Today
$33.69
Open Price
$36.45
Volume
409.85K
52 Week High
$37.97
52 Week Low
$18.64

Collections

BNR Earnings

-$0.38
-$0.25
-$0.13
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 25, Pre-Market

You May Also Like

SBUX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure